Pharmaceutical Research & Manufacturers of America
Annual Lobbying Totals: 1998 - 2023
Bills
Bills Lobbied
Bill Number | Congress | Title | No. of Reports & Specific Issues* |
---|---|---|---|
H.R.5376 | 118 | Share the Savings with Seniors Act | 21 |
H.R.830 | 118 | HELP Copays Act | 19 |
S.127 | 118 | Pharmacy Benefit Manager Transparency Act of 2023 | 17 |
S.1339 | 118 | Pharmacy Benefit Manager Reform Act | 15 |
H.R.3285 | 118 | Fairness for Patient Medications Act | 11 |
H.R.5378 | 118 | Lower Costs, More Transparency Act | 11 |
S.150 | 118 | Affordable Prescriptions for Patients Act of 2023 | 11 |
S.148 | 118 | Stop STALLING Act | 10 |
S.113 | 118 | Prescription Pricing for the People Act of 2023 | 10 |
S.142 | 118 | Preserve Access to Affordable Generics and Biosimilars Act | 9 |
S.79 | 118 | Interagency Patent Coordination and Improvement Act of 2023 | 9 |
H.R.3290 | 118 | To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. | 9 |
H.R.5376 | 117 | Inflation Reduction Act of 2022 | 8 |
S.1067 | 118 | Ensuring Timely Access to Generics Act of 2023 | 7 |
H.R.2880 | 118 | Protecting Patients Against PBM Abuses Act | 7 |
S.1114 | 118 | Expanding Access to Low-Cost Generics Act of 2023 | 7 |
S.1375 | 118 | HELP Copays Act | 6 |
S.2333 | 118 | Pandemic and All-Hazards Preparedness and Response Act | 6 |
H.R.2666 | 118 | MVP Act | 6 |
H.R.3561 | 118 | PATIENT Act of 2023 | 6 |
H.R.6283 | 118 | DRUG Act | 6 |
S.315 | 118 | TRACK Act of 2023 | 6 |
H.R.1790 | 118 | Biologics Competition Act of 2023 | 6 |
H.R.2679 | 118 | Pharmacy Benefits Manager Accountability Act | 6 |
H.R.3858 | 118 | No Free TRIPS Act | 6 |
S.1214 | 118 | RARE Act | 6 |
S.574 | 118 | Increasing Prescription Drug Competition Act | 6 |
S.1967 | 118 | PBM Act | 5 |
S.2131 | 118 | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 | 5 |
H.R.4368 | 118 | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 | 5 |
S.476 | 118 | Maintaining Investments in New Innovation Act | 5 |
S.1542 | 118 | DRUG Act | 5 |
H.R.4507 | 118 | Transparency in Coverage Act of 2023 | 5 |
H.R.3433 | 118 | Give Kids a Chance Act of 2023 | 5 |
S.2973 | 118 | Modernizing and Ensuring PBM Accountability Act | 5 |
S.2226 | 118 | National Defense Authorization Act for Fiscal Year 2024 | 4 |
H.R.3281 | 118 | Transparent PRICE Act | 4 |
H.R.2811 | 118 | Limit, Save, Grow Act of 2023 | 4 |
H.R.1717 | 118 | Interagency Patent Coordination and Improvement Act of 2023 | 4 |
H.R.4822 | 118 | Health Care Price Transparency Act of 2023 | 4 |
H.R.198 | 118 | Drug Pricing Transparency and Accountability Act | 4 |
H.R.2670 | 118 | National Defense Authorization Act for Fiscal Year 2024 | 4 |
S.1264 | 118 | SMART Prices Act | 4 |
H.R.5539 | 118 | ORPHAN Cures Act | 4 |
S.2840 | 118 | Bipartisan Primary Care and Health Workforce Act | 4 |
H.R.485 | 118 | Protecting Health Care for All Patients Act of 2023 | 4 |
S.775 | 118 | Increasing Transparency in Generic Drug Applications Act | 4 |
S.2624 | 118 | Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 | 4 |
H.R.3746 | 118 | Fiscal Responsibility Act of 2023 | 4 |
H.R.3810 | 118 | Drug Origin Transparency Act of 2023 | 3 |
H.R.4421 | 118 | To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes. | 3 |
H.R.5429 | 118 | Medication Affordability and Patent Integrity Act | 3 |
H.R.2534 | 118 | PROTECT 340B Act of 2023 | 3 |
H.R.3791 | 118 | Improving DATA in Public Health Act | 3 |
S.1128 | 118 | Ensuring Access to Generic Medications Act | 3 |
S.2780 | 118 | Medication Affordability and Patent Integrity Act | 3 |
H.R.3008 | 118 | Drug Shortage Prevention Act of 2023 | 3 |
H.R.5391 | 118 | Protecting Patient Access to Cancer and Complex Therapies Act | 3 |
S.1834 | 118 | No Free TRIPS Act | 3 |
S.935 | 118 | Fair Accountability and Innovative Research Drug Pricing Act of 2023 | 3 |
S.2140 | 118 | Patent Eligibility Restoration Act of 2023 | 3 |
H.R.5894 | 118 | Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. | 3 |
H.R.2500 | 118 | Protecting Americans from Unsafe Drugs Act of 2023 | 3 |
H.R.3793 | 118 | Ensuring Access to Lifesaving Drugs Act of 2023 | 3 |
S.1355 | 118 | PASTEUR Act of 2023 | 3 |
H.R.2816 | 118 | Pharmacy Benefit Manager Sunshine and Accountability Act | 3 |
S.6 | 118 | Balanced Budget Accountability Act | 3 |
H.R.4508 | 118 | Hidden Fee Disclosure Act | 2 |
S.2474 | 118 | Share the Savings with Seniors Act | 2 |
S.1906 | 118 | Promising Pathway Act | 2 |
S.2115 | 118 | Medical Supply Chain Resiliency Act | 2 |
S.2220 | 118 | A bill to amend title 35, United States Code, to invest in inventors in the United States, maintain the United States as the leading innovation economy in the world, and protect the property rights of the inventors that grow the economy of the United States, and for other purposes. | 2 |
H.R.4692 | 118 | Increasing Prescription Drug Competition Act | 2 |
H.R.5475 | 118 | Prohibiting Adversarial Patents Act of 2023 | 2 |
H.R.3284 | 118 | Providers and Payers COMPETE Act | 2 |
H.R.167 | 118 | Patient Access to Urgent-Use Pharmacy Compounding Act of 2023 | 2 |
H.R.4370 | 118 | To amend title 35, United States Code, to invest in inventors in the United States, maintain the United States as the leading innovation economy in the world, and protect the property rights of the inventors that grow the economy of the United States, and for other purposes. | 2 |
H.R.2471 | 118 | Vote Without Fear Act | 2 |
S.2305 | 118 | A bill to improve the requirements for making a determination of interchangeability of a biological product and its reference product. | 2 |
S.2764 | 118 | Protecting Patient Access to Cancer and Complex Therapies Act of 2023 | 2 |
H.R.4895 | 118 | Lowering Drug Costs for American Families Act | 2 |
H.R.4988 | 118 | Modern Authentication of Pharmaceuticals Act of 2023 | 2 |
H.R.4882 | 118 | Clinical Laboratory Price Transparency Act of 2023 | 2 |
H.R.6684 | 118 | Improving Efficiency to Increase Competition Act | 2 |
S.3430 | 118 | Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 | 2 |
H.R.4307 | 118 | Medical Supply Chain Resiliency Act | 2 |
S.845 | 118 | Short on Competition Act | 1 |
S.2321 | 118 | Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024 | 1 |
S.2456 | 118 | A bill to amend title XVIII of the Social Security Act to limit beneficiary cost-sharing to the net price of covered part D drugs. | 1 |
H.R.405 | 118 | Essential Medicines Strategic Stockpile Act of 2023 | 1 |
H.R.5547 | 118 | Maintaining Investments in New Innovation Act | 1 |
H.R.5801 | 118 | Preventing Overdoses with Test Strips Act | 1 |
S.1217 | 118 | Ending the Prescription Drug Kickback Act of 2023 | 1 |
H.R.456 | 118 | Fairness in Orphan Drug Exclusivity Act | 1 |
S.1250 | 118 | Drug-price Transparency for Consumers Act of 2023 | 1 |
S.1374 | 118 | Patient Right to Shop Act | 1 |
S.954 | 118 | Affordable Insulin Now Act of 2023 | 1 |
H.R.2959 | 118 | Health Savings Act of 2023 | 1 |
H.R.3093 | 118 | Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023 | 1 |
H.R.3421 | 118 | Medicare for All Act | 1 |
H.R.885 | 118 | TRACK Act of 2023 | 1 |
S.1491 | 118 | Pharmacy and Medically Underserved Areas Enhancement Act | 1 |
S.3799 | 117 | PREVENT Pandemics Act | 1 |
S.898 | 118 | Merchant Category Code Neutrality Act | 1 |
H.R.133 | 118 | Mandating Exclusive Review of Individual Treatments (MERIT) Act | 1 |
H.R.2408 | 118 | Access to Innovative Treatments Act of 2023 | 1 |
S.4338 | 117 | Increasing Transparency in Generic Drug Applications Act | 1 |
S.2495 | 118 | Protecting Athletes, Schools, and Sports Act of 2023 | 1 |
S.2076 | 117 | PASTEUR Act of 2021 | 1 |
H.R.2707 | 118 | MADE in America Act | 1 |
H.R.2893 | 118 | Seniors Securing Access to Vital and Essential Prescription Drugs Act | 1 |
H.R.6275 | 118 | Protecting Consumer Access to Generic Drugs Act of 2023 | 1 |
H.R.1503 | 118 | Prescription Information Modernization Act of 2023 | 1 |
H.R.1613 | 118 | Drug Price Transparency in Medicaid Act of 2023 | 1 |
H.R.4408 | 118 | To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. | 1 |
S.1589 | 118 | Safeguarding Patients and Taxpayers Act | 1 |
S.4543 | 117 | James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 | 1 |
H.R.7032 | 118 | Congressional Budget Office Data Sharing Act | 1 |
S.1450 | 118 | Cutting Medicare Prescription Drug Prices in Half Act | 1 |
H.R.4220 | 118 | Dental Care for Our Troops Act | 1 |
H.R.4390 | 117 | PROTECT 340B Act of 2021 | 1 |
H.R.6282 | 118 | Humane Accountability Act | 1 |
H.R.6436 | 118 | Stopping Pharma’s Ripoffs and Drug Savings For All Act | 1 |
H.R.6833 | 118 | Improve and Enhance the Work Opportunity Tax Credit Act | 1 |
H.R.7666 | 117 | Restoring Hope for Mental Health and Well-Being Act of 2022 | 1 |
S.2495 | 117 | Protecting our Pharmaceutical Supply Chain from China Act of 2021 | 1 |
S.1476 | 118 | Pharmaceutical Research Transparency Act of 2023 | 1 |
H.R.3839 | 118 | To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. | 1 |
H.R.4115 | 118 | Lower Drug Costs for Families Act | 1 |
S.3393 | 118 | SUPPORT for Patients and Communities Reauthorization Act | 1 |
H.R.5893 | 118 | Commerce, Justice, Science, and Related Agencies Appropriations Act, 2024 | 1 |
H.R.6833 | 117 | Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 | 1 |
H.R.7032 | 117 | Increasing Transparency in Generic Drug Applications Act of 2022 | 1 |
H.R.2617 | 118 | Choices for Stranded Passengers Act of 2023 | 1 |
H.R.3134 | 118 | Emergency Access to Insulin Act of 2023 | 1 |
S.562 | 118 | Emmett Till and Mamie Till-Mobley and Roberts Temple National Historic Site Act | 1 |
S.1497 | 118 | Emergency Access to Insulin Act of 2023 | 1 |
S.1130 | 118 | Health Care PRICE Transparency Act | 1 |
H.R.447 | 118 | MMEDS Act of 2023 | 1 |
H.R.2617 | 117 | Consolidated Appropriations Act, 2023 | 1 |
H.R.3160 | 118 | Pharmaceutical Research Transparency Act of 2023 | 1 |
*Each quarterly filing is treated as a separate report. |
Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, contact OpenSecrets: [email protected]